Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO Rep
2009 Oct 01;1010:1154-60. doi: 10.1038/embor.2009.179.
Show Gene links
Show Anatomy links
Vesicular stomatitis virus inhibits mitotic progression and triggers cell death.
Chakraborty P
,
Seemann J
,
Mishra RK
,
Wei JH
,
Weil L
,
Nussenzveig DR
,
Heiber J
,
Barber GN
,
Dasso M
,
Fontoura BM
.
???displayArticle.abstract???
Vesicular stomatitis virus (VSV) infects and kills a wide range of cell types; however, the mechanisms involved in VSV-mediated cell death are not fully understood. Here we show that VSV infection interferes with mitotic progression, resulting in cell death. This effect requires the interaction of VSV matrix (M) protein with the Rae1-Nup98 complex in mitosis, which is associated with a subset of ribonucleoproteins (RNPs). VSV displaced Rae1 from spindle poles, caused spindle abnormalities and triggered substantial cell death during metaphase. These effects were attenuated in cells infected with VSV expressing a mutant M protein that does not bind efficiently to the Rae1-Nup98-RNP complex. In cells that progressed to late mitosis, M protein prevented proper nuclear formation and chromatin decondensation. VSV is an oncolytic (anti-tumour) agent as it preferentially replicates and kills tumour cells. As tumour cells have a high mitotic index, VSV-mediated mitotic cell death probably contributes to its oncolytic activity.
Balachandran,
Defective translational control facilitates vesicular stomatitis virus oncolysis.
2004,
Pubmed
Barber,
Vesicular stomatitis virus as an oncolytic vector.
2004,
Pubmed
Barber,
VSV-tumor selective replication and protein translation.
2005,
Pubmed
Blower,
A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly.
2005,
Pubmed
,
Xenbase
Blower,
Genome-wide analysis demonstrates conserved localization of messenger RNAs to mitotic microtubules.
2007,
Pubmed
,
Xenbase
Chakraborty,
Nucleoporin levels regulate cell cycle progression and phase-specific gene expression.
2008,
Pubmed
Enninga,
Role of nucleoporin induction in releasing an mRNA nuclear export block.
2002,
Pubmed
Faria,
VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway.
2005,
Pubmed
Her,
Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus.
1997,
Pubmed
,
Xenbase
Jeganathan,
The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.
2005,
Pubmed
Obuchi,
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.
2003,
Pubmed
Oliere,
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.
2008,
Pubmed
Orjalo,
The Nup107-160 nucleoporin complex is required for correct bipolar spindle assembly.
2006,
Pubmed
,
Xenbase
Powers,
Reconstituted nuclei depleted of a vertebrate GLFG nuclear pore protein, p97, import but are defective in nuclear growth and replication.
1995,
Pubmed
,
Xenbase
Stojdl,
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.
2003,
Pubmed
Wang,
Golgi cisternal unstacking stimulates COPI vesicle budding and protein transport.
2008,
Pubmed
Wong,
Rae1 interaction with NuMA is required for bipolar spindle formation.
2006,
Pubmed
von Kobbe C,
Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98.
2000,
Pubmed